Last reviewed · How we verify
Erythromycin 4% topical gel formulation
At a glance
| Generic name | Erythromycin 4% topical gel formulation |
|---|---|
| Sponsor | Centre for Human Drug Research, Netherlands |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Intradermal LPS and Antibiotics (NA)
- Anti-inflammatory Effects of Topical Erythromycin and Clindamycin in Acne Patients (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: